| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Topiramate | FAERS: 16 | US FAERS | |
| 2 | Fingolimod Hydrochloride | FAERS: 9 | US FAERS | |
| 3 | Dimethyl Fumarate | FAERS: 8 | US FAERS | |
| 4 | Sunitinib | FAERS: 4 | US FAERS | |
| 5 | 4-Aminopyridine | FAERS: 3 | US FAERS | |
| 6 | Lapatinib | FAERS: 3 | US FAERS | |
| 7 | Glatiramer Acetate | FAERS: 2 | US FAERS | |
| 8 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 9 | Acetaminophen | FAERS: 1 | US FAERS | |
| 10 | Cysteamine | FAERS: 1 | US FAERS | |
| 11 | Droxidopa | FAERS: 1 | US FAERS | |
| 12 | Imiquimod | FAERS: 1 | US FAERS | |
| 13 | Lamotrigine | FAERS: 1 | US FAERS | |
| 14 | Memantine | FAERS: 1 | US FAERS | |
| 15 | NuvaRing | FAERS: 1 | US FAERS | |
| 16 | Octreotide | FAERS: 1 | US FAERS | |
| 17 | Oseltamivir | FAERS: 1 | US FAERS | |
| 18 | Ospemifene | FAERS: 1 | US FAERS | |
| 19 | Rivastigmine | FAERS: 1 | US FAERS | |
| 20 | Thyroxine | FAERS: 1 | US FAERS | |
| 21 | Ticagrelor | FAERS: 1 | US FAERS | |
| 22 | Trimethoprim, Sulfamethoxazole Drug Combination | FAERS: 1 | US FAERS | |
| 23 | ambrisentan | FAERS: 1 | US FAERS | |
| 24 | dabrafenib | FAERS: 1 | US FAERS | |
| 25 | gadoterate meglumine | FAERS: 1 | US FAERS | |
| 26 | idelalisib | FAERS: 1 | US FAERS | |
| 27 | palbociclib | FAERS: 1 | US FAERS | |
| 28 | teriflunomide | FAERS: 1 | US FAERS | |
| 29 | treprostinil | FAERS: 1 | US FAERS | |
| 30 | Temozolomide | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120267
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.